Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clostridium Difficile Diarrhea”

115 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 115 results

Not applicableLooking for participantsNCT03895593
What this trial is testing

Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections

Who this might be right for
Intestinal InfectionClostridioides Difficile InfectionAntibiotic-associated Diarrhea
The Second Hospital of Nanjing Medical University 100
Not applicableLooking for participantsNCT06839209
What this trial is testing

Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

Who this might be right for
Clostridium; Difficile, As Cause of Disease Classified ElsewhereClostridium Difficile Diarrhea
ABResearch S.r.l. 18
Large-scale testing (Phase 3)Study completedNCT00328263
What this trial is testing

Efficacy and Safety of BIO-K + CL1285 in Prevention of Antibiotic-associated Diarrhea in Hospitalized Adult Patients

Who this might be right for
DiarrheaClostridium Infections
Bio-K Plus International Inc. 472
Testing effectiveness (Phase 2)Study completedNCT01232595
What this trial is testing

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

Who this might be right for
Moderate Clostridium Difficile Infection
Novartis Pharmaceuticals 109
Post-approval studies (Phase 4)WithdrawnNCT00304863
What this trial is testing

Addition of Lactobacillus to Metronidazole in Treatment of CDAD

Who this might be right for
EnterocolitisPseudomembranous ColitisAntibiotic-associated Colitis
Michael E. DeBakey VA Medical Center
Not applicableUnknownNCT04801862
What this trial is testing

Natural History of Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile InfectionHealth Care Associated InfectionNosocomial Infection
Hospital Universitario de Valme 750
Not applicableUnknownNCT03964844
What this trial is testing

Clostridium Difficile Infection (CDI) in Hematologic Patients.

Who this might be right for
C.Difficile Diarrhea
Hospital General Universitario Gregorio Marañon 450
Post-approval studies (Phase 4)Study completedNCT03388268
What this trial is testing

TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment

Who this might be right for
Clostridium Difficile InfectionDiarrhea
Washington University School of Medicine 15
Testing effectiveness (Phase 2)Study completedNCT02626104
What this trial is testing

Bovine Lactoferrin and Antibiotic-associated Diarrhoea.

Who this might be right for
Antibiotic Associated Diarrhoea
Medical University of Warsaw 156
Not applicableStudy completedNCT03321578
What this trial is testing

Hospital Onset Diarrhoea Investigation

Who this might be right for
Diarrhea
The Leeds Teaching Hospitals NHS Trust 230
Testing effectiveness (Phase 2)Looking for participantsNCT04305769
What this trial is testing

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Who this might be right for
Clostridioides Difficile InfectionClostridium Difficile InfectionClostridium Difficile Diarrhea+1 more
University of Virginia 260
Post-approval studies (Phase 4)Ended earlyNCT02200328
What this trial is testing

Efficacy of Metronidazole Prophylaxis Against Clostridium Difficile-Associated Diarrhea in High Risk Adult Patients

Who this might be right for
Clostridium Difficile Diarrhea
Alison Schneider 76
Testing effectiveness (Phase 2)Ended earlyNCT01570634
What this trial is testing

Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection

Who this might be right for
Diarrhoea, Clostridium Difficile
Salient Pharmaceuticals Incorporated 2
Not applicableUnknownNCT05430269
What this trial is testing

Faecal Bacteriotherapy for Postantibiotic Diarrhoea in Critically Ill Patients

Who this might be right for
Diarrhea Caused by DrugClostridium Difficile Infections
Charles University, Czech Republic 36
Not applicableUnknownNCT02681068
What this trial is testing

MicroTrans - A Multicenter Registry of Fecal Microbiota Transplantation

Who this might be right for
Clostridium Infections
University of Cologne 1,000
Testing effectiveness (Phase 2)Study completedNCT02299570
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Enterocolitis Clostridium Difficile Recurrent
Rebiotix Inc. 150
Not applicableStudy completedNCT02127814
What this trial is testing

Lactobacillus Reuteri in the Prevention of Antibiotic Associated-diarrhea and Clostridium Difficile

Who this might be right for
Antibiotic-associated DiarrheaClostridium Difficile
Case Western Reserve University 73
Not applicableUnknownNCT06019312
What this trial is testing

L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer Patients

Who this might be right for
Colorectal CancerClostridioides Difficile InfectionDiarrhea
Medical University of Gdansk 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06948461
What this trial is testing

A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections.

Who this might be right for
Irritable Bowel Syndrome, Diarrhea-Predominant (IBS-D)Recurrent Clostridioides Difficile Infection (rCDI)Fecal Microbiota Therapy (FMT)+2 more
PharmaPlanter Technologies Inc 63
Large-scale testing (Phase 3)Ended earlyNCT00466635
What this trial is testing

Assess the Safety, Tolerability, Effectiveness and Absorption of Exodif™ Tablets in Clostridium Difficile-associated Diarrhea

Who this might be right for
Enterocolitis, PseudomembranousDiarrheaClostridium Difficile
Genzyme, a Sanofi Company 65
Load More Results